Opportunities and challenges in controlling metabolic dysfunction related fatty liver disease (MAFLD): Editorial on "Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation" [0.03%]
代谢功能紊乱相关脂肪肝病（MAFLD）防治的机遇与挑战——“MARC1 p.A165风险等位基因表达下调通过增加β氧化减少肝细胞脂质蓄积”述评
Jian Xu,Gang Shi,Tao Sheng et al.
Jian Xu et al.
Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation [0.03%]
肝失代偿与巨细胞病毒再激活的关系研究
Changze Hong,Zuxiong Huang,Yingli He et al.
Changze Hong et al.
Background/aims: The role of reactivation of Human cytomegalovirus (HCMV) in determining outcomes of cirrhotic patients with acute decompensation (AD) is unknown. We aimed to investigate HCMV incidence and potential corre...
Editorial on "Risk stratification by noninvasive tests in patients with metabolic dysfunctionassociated steatotic liver disease": Rethinking first-line screening in MASLD: beyond the limitations of Fibrosis-4 index [0.03%]
关于《代谢功能障碍相关肝脂肪变性患者非侵入性检查的风险分层：“代谢关联性肝脂肪变性一线筛查的再思考：超越FIB-4指数的限制》的观点评论
Han Ah Lee,Young Youn Cho,Hyung Joon Kim
Han Ah Lee
Jialin Wu,Xinyi Deng,Junyang Luo et al.
Jialin Wu et al.
Portal vein thrombosis (PVT) is characterized by the formation of a thrombus (blood clot) within the portal vein system, including main portal vein and its intrahepatic portal vein branches, and may extend to the superior mesenteric vein or...
Ye Feng,Chengfu Xu
Ye Feng
Critical Flaws in the Molecular Classification of HCC Based on Metabolic Zonation [0.03%]
基于代谢分带的肝细胞癌分子分类的缺陷
Yongzhi Xie,Xiangyu Zhu,Qi Liang
Yongzhi Xie
Factors associated with hepatitis B mother-to-child transmission in a national prevention program [0.03%]
全国乙肝母婴阻断项目中的母亲向孩子传染因素分析
Moran Ki,Byung-Woo Kim,Dahye Baik et al.
Moran Ki et al.
Background & aims: Hepatitis B virus (HBV) mother-to-child transmission (MTCT) remains a global health concern, with over 90% of perinatal infections leading to chronic HBV. To evaluate long-term trends in MTCT rates and ...
Reply to the letter to the editor on "Re: "Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States" [0.03%]
关于“有关‘美国性别差异酒精相关性肝病及饮酒归因性肿瘤亚型的差异’来信”的回复
Pojsakorn Danpanichkul,Luis Antonio Diaz,Juan Pablo Arab et al.
Pojsakorn Danpanichkul et al.